Stromal FOXF2 Suppresses Prostate Cancer Progression and Metastasis by Enhancing Antitumor Immunity

Researchers showed that increasing prostatic stromal Foxf2 suppressed the growth and progression of both syngeneic and autochthonous mouse prostate cancer models in an immunocompetent context.
[Nature Communications]
Full Article

Stay up-to-date with your field!

Subscribe for free weekly science newsletters.

Related News